EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access

AI in Psoriatic Disease: Scoping Review

Richard Barlow iD, Anthony Bewley iD, Maria Angeliki Gkini iD

JMIR Dermatology · 16.10.2024 · 7 · e50451

DOI: 10.2196/50451 ↗

Kurz gefasst

Scoping Review in der Zeitschrift JMIR Dermatology, online erschienen am 16.10.2024. Verfasst von Richard Barlow und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom. Hauptthemen laut MEDLINE: Psoriasis, Artificial Intelligence. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Artificial intelligence (AI) has many applications in numerous medical fields, including dermatology. Although the majority of AI studies in dermatology focus on skin cancer, there is growing interest in the applicability of AI models in inflammatory diseases, such as psoriasis. Psoriatic disease is a chronic, inflammatory, immune-mediated systemic condition with multiple comorbidities and a significant impact on patients’ quality of life. Advanced treatments, including biologics and small molecules, have transformed the management of psoriatic disease. Nevertheless, there are still considerable unmet needs. Globally, delays in the diagnosis of the disease and its severity are common due to poor access to health care systems. Moreover, despite the abundance of treatments, we are unable to predict which is the right medication for the right patient, especially in resource-limited settings. AI could be an additional tool to address those needs. In this way, we can improve rates of diagnosis, accurately assess severity, and predict outcomes of treatment.

Objective

This study aims to provide an up-to-date literature review on the use of AI in psoriatic disease, including diagnostics and clinical management as well as addressing the limitations in applicability.

Methods

We searched the databases MEDLINE, PubMed, and Embase using the keywords “AI AND psoriasis OR psoriatic arthritis OR psoriatic disease,” “machine learning AND psoriasis OR psoriatic arthritis OR psoriatic disease,” and “prognostic model AND psoriasis OR psoriatic arthritis OR psoriatic disease” until June 1, 2023. Reference lists of relevant papers were also cross-examined for other papers not detected in the initial search.

Results

Our literature search yielded 38 relevant papers. AI has been identified as a key component in digital health technologies. Within this field, there is the potential to apply specific techniques such as machine learning and deep learning to address several aspects of managing psoriatic disease. This includes diagnosis, particularly useful for remote teledermatology via photographs taken by patients as well as monitoring and estimating severity. Similarly, AI can be used to synthesize the vast data sets already in place through patient registries which can help identify appropriate biologic treatments for future cohorts and those individuals most likely to develop complications.

Conclusions

There are multiple advantageous uses for AI and digital health technologies in psoriatic disease. With wider implementation of AI, we need to be mindful of potential limitations, such as validation and standardization or generalizability of results in specific populations, such as patients with darker skin phototypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisArtificial IntelligenceHumansSeverity of Illness IndexMachine LearningArthritis, PsoriaticQuality of Life

Stichwörter der Autor:innen

artificial intelligencebiologicsmachine learningmobile phoneprognostic modelspsoriasispsoriatic arthritispsoriatic disease

Autor:innen und Institutionen

  • Dermatology Department, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Department of Dermatology, The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.

ORCID-Profile: Richard Barlow, Anthony Bewley, Maria Angeliki Gkini

Zitieren

APA

Barlow, R., Bewley, A., & Gkini, M. A. (2024). AI in Psoriatic Disease: Scoping Review. JMIR Dermatology, 7, e50451. https://doi.org/10.2196/50451

Vancouver

Barlow R, Bewley A, Gkini MA. AI in Psoriatic Disease: Scoping Review. JMIR Dermatology. 2024;7:e50451. doi:10.2196/50451

BibTeX
@article{Barlow2024,
  author = {Barlow, Richard and Bewley, Anthony and Gkini, Maria Angeliki},
  title = {AI in Psoriatic Disease: Scoping Review},
  journal = {JMIR Dermatology},
  year = {2024},
  volume = {7},
  pages = {e50451},
  doi = {10.2196/50451}
}
Kostenlos starten →